论文部分内容阅读
目的探讨布地奈德结合咳喘宁口服液治疗在抗小儿支气管哮喘复发中的效果。方法选择于某院治疗的支气管哮喘患儿共78例,根据治疗方式不同分为观察组及对照组,每组各39例。观察组在对照组用药基础上给予中药治疗,对比两组患儿治疗效果,记录患儿哮喘复发率、复发次数等情况。结果两组疗效对比显示,观察组总有效率为87.2%,对照组为69.2%,观察组治疗有效率显著高于对照组,差异有统计学意义,P﹤0.05。治疗后随访中对照组复发23例,复发率59.0%。观察组复发9例,复发率23.7%,两组复发率对比差异有统计学意义,P﹤0.05。对照组哮喘发作次数为(4.23±2.01)次,观察组为(2.48±1.27)次,两组发作次数对比差异有统计学意义,P﹤0.05。结论布地奈德结合咳喘宁口服液抗小儿支气管哮喘复发疗效显著,未见明显不良反应,值得临床推广。
Objective To investigate the effect of budesonide combined with Kechuanning oral liquid on the recurrence of bronchial asthma in children. Methods A total of 78 children with bronchial asthma who were treated in a hospital were divided into observation group and control group according to different treatment methods, with 39 cases in each group. The observation group was treated with traditional Chinese medicine on the basis of the control group. The treatment effect was compared between the two groups, and the recurrence rate and the number of recurrence were recorded. Results The two groups showed that the total effective rate was 87.2% in the observation group and 69.2% in the control group. The treatment efficiency in the observation group was significantly higher than that in the control group, with a significant difference (P <0.05). After treatment, the control group recurred in 23 cases, the recurrence rate was 59.0%. The recurrence rate was 23.7% in the observation group with recurrence rate of 9 cases (P <0.05). The number of asthma attacks in the control group was (4.23 ± 2.01) times and in the observation group was (2.48 ± 1.27) times, the difference was statistically significant (P <0.05). Conclusion Budesonide combined with Kechuanning oral anti-bronchial asthma relapse significant effect, no significant adverse reactions, is worth clinical promotion.